biotech · Huntington’s Disease · Amyotrophic Lateral Sclerosis (ALS)
iQure Pharma
uniQure biopharma B.V.
iQure Pharma clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Princeton, USA HQ
2019 Founded
9 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Princeton, USA
- Founded
- 2019
- Employees
- 9
- Programs
- 2
- Drugs
- 2
- Patents
- 0
iQure Pharma projects
2 ClinicalTrials.gov programs sponsored by iQure Pharma.
iQure Pharma has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does iQure Pharma have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.